PatientsCann UK | Free the weed? The case for self-sustainability
Where this article stands We are reporting on a campaign run by Legal Growers UK, an organisation we are not part of. We share it so patients can read it and make up their own minds. This is not legal or medical advice, and it is not an endorsement of any party or campaign.

Why this matters

The market never left
The campaign argues prohibition did not remove the cannabis trade. It handed control to an illegal market that checks no age, tests no product, and pays no tax.
Patient access
Many patients tell us a legal prescription can work well, but the cost of it puts safe, legal medicine out of their reach.
Self-sustainability
Our own belief is plain: patients should have a route to grow their own, safely and legally, at home.

The news

A national campaign for a regulated British model

On Friday 17 July 2026, Legal Growers UK launched a national campaign for what it calls a careful, safe British model for regulating cannabis. The group is a not-for-profit, run by volunteers from across the United Kingdom.1

Its argument is short. Prohibition has not made cannabis go away. Instead, the campaign says, the trade has been left in the hands of an illegal market that does not check age, does not test its product, and does not pay tax. It wants cannabis placed under clear, enforceable rules so that government, police, and local councils have better tools to keep the public safe. The campaign hashtag is #LegalGrowersNotTraffickers.

To meet the public face to face, the volunteer team is at Borofest 2026, the Borofest Glass Festival, which runs from 17 to 20 July at Overstone, Northampton. The organisation says it is a growing team and welcomes new volunteers and supporters.

The country is hurting. Our streets and schools are no longer safe, patients have poor access, and it is a drain on the public purse when other countries have profited to the tune of billions.
Dan Balderson, Chief Executive, Legal Growers UK

The detail

What the campaign proposes

Rules to protect people

  • Sales to adults only, with strict age verification.
  • Plain packaging, free of cartoon-style designs.
  • Outlets kept away from schools and playgrounds.
  • Products laboratory-tested and labelled with their exact strength.
  • Employers keep the right to require staff to be sober and fit for duty.

Fairness and funding

  • Lawful use in a person's own private time protected.
  • Councils given clearer powers over nuisance such as smoke or smell.
  • Old, minor cannabis records cleared automatically.
  • A share of tax revenue directed to NHS mental health services, youth education, and enforcement.

These are the campaign's own proposals, summarised in plain terms. We set them out so you can weigh them up, not to tell you whether to back them.

Our view

The case for self-sustainability

Here is where we do take a side, and we are clear about it. PatientsCann UK believes that patients should be able to look after their own health. For some, that includes the right to grow a small amount of their own medicine at home. We call this self-sustainability.

The reason is simple, and it comes straight from patients. A prescription can be safe and effective, but many people cannot afford one. When the legal route is too expensive, patients are pushed towards a market they cannot trust, or they go without. Growing your own is low cost, it keeps money away from organised crime, and it puts a patient back in control of their own care.

This is not a call to ignore safety. It is a call to give patients a fair, legal path to self-sustainability, whatever wider route the country chooses. On that narrow point, we support the spirit of freeing the plant, so that the people who rely on it are no longer treated as criminals.

It aligns with all my values: community safeguarding, and people like me cannot afford a prescription. My initials are GYO, Grow Your Own, and it is about time.
Gary Youds, Chillin' Rooms Owner and Legal Growers UK Board Member

The evidence

What the international research shows

The campaign points to evidence from abroad. A second annual evaluation of Switzerland's regulated cannabis pilot trials, produced for the Swiss Federal Office of Public Health and published in November 2025, found that controlled legal access moved adult buyers away from the illegal market. It recorded no negative effects on public order or health to date.2

Legal Growers UK cites this as international evidence, and does not claim the Swiss model is the same as its own plan. We would add our own note of care: one country's pilot is not proof for another, and early findings like these should be read carefully, not treated as a promise.

Read evidence with care. Early results from one country's trial cannot tell us exactly what would happen in Britain. They are a signal worth studying, not a guarantee.

Over to you

Legalisation or decriminalisation. Where do you stand?

Choose your stance: legalisation, decriminalisation, or still deciding

These two words often get used as if they mean the same thing. They do not. Pick the one closest to your view to see what it would mean in plain terms, then submit your answer. Responses are anonymous, and no personal details are collected.

Where PatientsCann UK stands. We will not tell you how to answer that question, and we are not part of the Legal Growers UK campaign. What we do believe is simple: patients deserve a route to self-sustainability, including the right to grow their own medicine at home.

Read it, and make up your own mind

You do not have to take our word for it, or anyone else's. Read the campaign in full, look at the evidence, and decide what you believe.

References

Sources

  1. 1Legal Growers UK (2026) Legal Growers UK launches national campaign for a safer, regulated British cannabis model. Press release, 17 July. Available at: legalgrowers.org (Accessed: 21 July 2026).
  2. 2University of Lausanne and University of Applied Sciences and Arts Northwestern Switzerland (2025) Analysis of Results from Cannabis Pilot Trials in Swiss Cities, Part Two, mid-2024 to mid-2025. Produced for the Swiss Federal Office of Public Health. Published 17 November. Available from: Swiss Federal Office of Public Health.
Written by the PatientsCann UK Editorial Team News and Advocacy, PatientsCann UK.